ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 631306 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 631306; 2) Community: the network communities that were significantly associated with the response to NSC 631306; 3) Molecule: the relationships between components within communities and NSC 631306; 4) MDR: the compounds that were significantly associated with the NSC 631306.

NSC Compound Enrichment Correlation
NSC 748533 1-[2-(3-Chlorophenyl)-2-oxoethyl]-2-acetylbenzimidazole 0.0102962192514439 0.42519124
NSC 758682 ARTENIMOL 0.0102962192514439 0.42503111
NSC 92504 Null 0.0102962192514439 0.32341086
NSC 163062 TRIPTOLIDE 0.0107933723273943 0.27330192
NSC 266047 1,2-Cyclohexanediamine, platinum complex, (1R-trans)- (9CI) 0.0107933723273943 0.52348743
NSC 321239 Mercury, (2-hydroxy-5-nitrophenyl)(6-thioguanosinato-N(7),S(6))- 0.0107933723273943 0.41000325
NSC 349447 Indolo[2,1-b]quinazoline-6,12-dione (8CI9CI) 0.0107933723273943 0.31524483
NSC 373355 Saframycin R 0.0107933723273943 0.20422044
NSC 381811 Poly(oxy-1,2-ethanediyl), .alpha.-methyl-.omega.-[[3- (5-fluoro-1,2,3,4-tetrahydro-2,4-dioxo-1-pyrimidinyl)- 1-oxopropyl]oxy]- 0.0107933723273943 0.16373454
NSC 529108 4-Fluoro-D,L-tryptophan 0.0107933723273943 0.34365001
Total:134  Current:40    [First] [Prev] [Next] [Last]